View up-to-date information on Forty Seven Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4052040A1 | Application | ANTI-CD47 UND ANTI-CD20 BASIERTE BEHANDLUNG VON BLUTKREBS | A61K2039/507; A61K2039/545; A61K2039/55; A61P35/00; A61P35/02; A61P39/00; C07K16/2803; C07K16/2887; G01N2333/70596; G01N2800/52; G01N33/5052; G01N33/57426 | September 07, 2022 |
| EP4045083A1 | Application | KOMBINATIONSTHERAPIEN ZUR BEHANDLUNG VON MYELODYSPLASTISCHEN SYNDROMEN UND AKUTER MYELOISCHER LEUKÄMIE | A61K2039/505; A61K2039/545; A61K2039/572; A61K2039/575; A61K2039/585; A61K2300/00; A61K31/706; A61K39/39; A61K39/3955; A61K45/06; A61K9/0019; A61P35/02; C07K16/2803; C07K16/2896; C07K2317/24; C07K2317/76 | August 24, 2022 |
| AU2022204618A1 | Application | Anti-SIRP-alpha antibodies and related methods | A61K2039/505; A61K39/3955; A61P37/02; C07K16/2803; C07K16/2896; C07K2317/21; C07K2317/24; C07K2317/33; C07K2317/51; C07K2317/515; C07K2317/52; C07K2317/56; C07K2317/565; C07K2317/71; C07K2317/73; C07K2317/76; C07K2317/92 | July 21, 2022 |
| JP7099957B2 | Grant | ヒト化、マウスまたはキメラ抗ＣＤ４７モノクローナル抗体 | A61K2039/505; A61P35/00; A61P43/00; C07K16/2803; C07K2317/24; C07K2317/31; C07K2317/33; C07K2317/34; C07K2317/54; C07K2317/55; C07K2317/73; C07K2317/76; C07K2317/92 | July 12, 2022 |
| CN114716552A | Application | 人源化、小鼠或嵌合抗CD47单克隆抗体 | A61K2039/505; A61P35/00; A61P43/00; C07K16/2803; C07K2317/24; C07K2317/31; C07K2317/33; C07K2317/34; C07K2317/54; C07K2317/55; C07K2317/73; C07K2317/76; C07K2317/92 | July 08, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer